Apellis Pharmaceuticals ( (APLS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Apellis Pharmaceuticals’ stock movement is influenced by promising developments in their research on geographic atrophy and rare kidney diseases. Mizuho has raised the company’s price target, reflecting the potential impact of these advancements, including a significant Phase 3 study on Pegcetacoplan for kidney transplants.
More about Apellis Pharmaceuticals
YTD Price Performance: -9.38%
Average Trading Volume: 2,439,381
Technical Sentiment Signal: Hold
Current Market Cap: $3.8B
For further insights into APLS stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.